A groundbreaking drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to ...
The test was developed by researchers at the US-based not-for-profit Brain Chemistry Labs, who analysed 788 blood samples – roughly half from patients with the disease and half from people without it.
Johnathan Cooper-Knock receives funding from TargetALS, the ALS Association, the MND Association and the Lister Institute of Preventive Medicine. Pamela J. Shaw has received funding from The Motor ...